Characterization of Methylation Patterns in Lung Cancer (Lung-RND-001)

Characterization of Methylation Patterns in Lung Cancer (Lung-RND-001) - Lung-RND-001

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON45678

Enrollment

200

Registered

2017-05-12

Start date

2017-07-06

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Single blood draw of 30 ml.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Males and females Test group: subjects18 years and above with a suspicion of a cancerous tumor in the lungs or patients who have already been diagnosed with lung cancer, however did not yet undergo surgery and did not yet receive any treatment for the cancer (including, but not limited to chemotherapy and/or radiation). Control group: Smokers (currently or in the past) 50 years and above without cancer (current or previous) with preference to subjects which also diagnosed with COPD.

Exclusion criteria

Exclusion criteria: Test group: Subjects with cancer or history of cancer from any kind (besides lung cancer). Control group: Subjects with cancer or history of cancer from any kind.

Design outcomes

Primary

Measure	Time frame
Methylation patterns that are unique to lung cancer.	—

Secondary

Measure	Time frame
None	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)